China Biologic Produ
(CBPO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 93,776 | 63,898 | 29,655 | 96,113 | 78,931 |
| Depreciation Amortization | 6,741 | 4,539 | 2,409 | 7,748 | 5,696 |
| Income taxes - deferred | -55 | 168 | 503 | 3,484 | 935 |
| Accounts receivable | -16,229 | -18,836 | -9,178 | -2,191 | -7,510 |
| Accounts payable and accrued liabilities | 659 | 10,124 | 482 | 405 | 397 |
| Other Working Capital | -37,084 | -38,899 | -18,175 | -14,184 | -22,376 |
| Other Operating Activity | 24,460 | 13,568 | 10,846 | 2,140 | 8,036 |
| Operating Cash Flow | $72,268 | $34,561 | $16,542 | $93,514 | $64,108 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 6,609 | 6,609 |
| PPE Investments | -25,568 | -15,927 | -8,472 | -16,974 | -13,709 |
| Purchase Sale Intangibles | -4,199 | -4,206 | N/A | -4,677 | -2,834 |
| Other Investing Activity | -30,197 | -4,206 | 0 | -3,042 | -1,199 |
| Investing Cash Flow | $-55,765 | $-20,133 | $-8,472 | $-13,408 | $-8,299 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 44,500 | 44,500 |
| Debt Issued | N/A | N/A | N/A | 70,000 | 70,000 |
| Debt Repayment | -97,910 | N/A | N/A | -33,700 | -80,526 |
| Common Stock Issued | 7,221 | 771 | 450 | 3,860 | 2,258 |
| Common Stock Repurchased | 80,584 | 80,584 | N/A | -36,788 | -36,788 |
| Dividend Paid | -3,691 | -3,691 | -2,988 | -8,847 | -6,035 |
| Other Financing Activity | 63,441 | -65,637 | 375 | -181,854 | -117,951 |
| Financing Cash Flow | $49,644 | $12,028 | $-2,164 | $-142,828 | $-124,541 |
| Exchange Rate Effect | -4,307 | -662 | -739 | -597 | -828 |
| Beginning Cash Position | 80,820 | 80,820 | 80,820 | 144,139 | 144,139 |
| End Cash Position | 142,660 | 106,615 | 85,988 | 80,820 | 74,579 |
| Net Cash Flow | $61,840 | $25,795 | $5,167 | $-63,318 | $-69,560 |
| Free Cash Flow | |||||
| Operating Cash Flow | 72,268 | 34,561 | 16,542 | 93,514 | 64,108 |
| Capital Expenditure | -26,310 | -16,486 | -8,478 | -17,194 | -13,925 |
| Free Cash Flow | 45,958 | 18,075 | 8,064 | 76,320 | 50,183 |